We are live on
!
Find out more
GCM
Ghisallo Capital Management Portfolio holdings
AUM
$3.63B
1-Year Est. Return
30.51%
This Fund
S&P 500
This Quarter
Est. Return
-4.61%
1 Year Est. Return
+30.51%
3 Year Est. Return
+102.79%
5 Year Est. Return
+106.47%
10 Year Est. Return
–
AUM
$979M
AUM Growth
+$141M
(+17%)
Cap. Flow
+$200M
Cap. Flow
% of AUM
20.42%
Top 10 Holdings %
Top 10 Hldgs %
51.65%
Holding
173
New
54
Increased
7
Reduced
11
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rollins
ROL
|
+$101M |
| 2 |
Arm
ARM
|
+$66.4M |
| 3 |
Enbridge
ENB
|
+$63M |
| 4 |
AerCap
AER
|
+$46.2M |
| 5 |
Carlyle Group
CG
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RenaissanceRe
RNR
|
+$19.2M |
| 2 |
Agilon Health
AGL
|
+$17.3M |
| 3 |
Everest Group
EG
|
+$17.1M |
| 4 |
Cencora
COR
|
+$16.4M |
| 5 |
CCC
CCC Intelligent Solutions
CCC
|
+$15.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.51% |
| 2 | Technology | 18.14% |
| 3 | Energy | 14.52% |
| 4 | Industrials | 14.19% |
| 5 | Financials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Coherus Oncology
CHRS
$185M
| – | – |
-150,000
| Closed | -$641K |
|
|
127
Cencora
COR
$63.1B
| – | – |
-85,000
| Closed | -$16.4M |
|
128
CorMedix
CRMD
$577M
| – | – |
-250,000
| Closed | -$991K |
|
|
CVAC
129
DELISTED
CureVac
CVAC
| – | – |
-100,000
| Closed | -$1.04M |
|
|
CWAN
130
DELISTED
Clearwater Analytics
CWAN
| – | – |
-300,000
| Closed | -$4.76M |
|
131
Ducommun
DCO
$2.99B
| – | – |
-50,000
| Closed | -$2.18M |
|
132
Editas Medicine
EDIT
$442M
| – | – |
-974,618
| Closed | -$8.02M |
|
|
133
Everest Group
EG
$14.1B
| – | – |
-50,000
| Closed | -$17.1M |
|
134
Enlight Renewable Energy
ENLT
$11.6B
| – | – |
-28,223
| Closed | -$501K |
|
135
EverCommerce
EVCM
$1.78B
| – | – |
-75,000
| Closed | -$888K |
|
136
EVgo
EVGO
$503M
| – | – |
-500,000
| Closed | -$2M |
|
137
Global E Online
GLBE
$6.78B
| – | – |
-100,000
| Closed | -$4.09M |
|
138
SPDR Gold Trust
GLD
$143B
| – | – |
-16,200
| Closed | -$2.89M |
|
139
Gulfport Energy Corp
GPOR
$3B
| – | – |
-55,000
| Closed | -$5.78M |
|
140
Hayward Holdings
HAYW
$3.33B
| – | – |
-200,000
| Closed | -$2.57M |
|
|
HSAI
141
Hesai Group
HSAI
$3B
| – | – |
-150,000
| Closed | -$1.58M |
|
|
IAS
142
DELISTED
Integral Ad Science
IAS
| – | – |
-200,000
| Closed | -$3.6M |
|
143
Disc Medicine
IRON
$3.05B
| – | – |
-20,000
| Closed | -$888K |
|
144
Keurig Dr Pepper
KDP
$39.2B
| – | – |
-200,000
| Closed | -$6.25M |
|
145
Kimbell Royalty Partners
KRP
$1.49B
| – | – |
-75,000
| Closed | -$1.1M |
|
146
Kura Oncology
KURA
$869M
| – | – |
-45,000
| Closed | -$476K |
|
147
Kymera Therapeutics
KYMR
$8.89B
| – | – |
-50,000
| Closed | -$1.15M |
|
148
Lucid Motors
LCID
$2.64B
| – | – |
-200,000
| Closed | -$13.8M |
|
149
Lexicon Pharmaceuticals
LXRX
$1.05B
| – | – |
-500,000
| Closed | -$1.15M |
|
150
MKS Inc
MKSI
$20B
| – | – |
-20,476
| Closed | -$2.21M |
|
Similar funds
VI
ACM
SCM
OCM
SL
GCM
MTIM
HIM
Ghisallo Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Ghisallo Capital Management held 173 positions worth $979M, up 17% from $838M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Ghisallo Capital Management deployed $200M of net new capital in Q3 2023, opening 54 new positions and adding to 7 existing holdings. Its largest new stake was Rollins: 2,500,000 shares worth $93.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was RenaissanceRe, an estimated $19.2M trimmed.
- Ghisallo Capital Management's largest Q3 2023 buy was Rollins: 2,500,000 shares worth $93.3M.
- Ghisallo Capital Management added most to AerCap in Q3 2023, an estimated $46.2M increase.
- Ghisallo Capital Management's biggest Q3 2023 reduction was RenaissanceRe, cutting an estimated $19.2M.
- Ghisallo Capital Management fully exited Agilon Health in Q3 2023, selling an estimated $17.3M.
- Ghisallo Capital Management's ten largest holdings make up 52% of its $979M portfolio in Q3 2023.
- Ghisallo Capital Management opened 54 new positions and closed 58 in Q3 2023.
- Ghisallo Capital Management's portfolio value rose 17% quarter-over-quarter to $979M.
Based on Ghisallo Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.